Quick Answer
TAKEDA PHARMACEUTICAL CO LTD reported Research And Development Expense of $730.23 billion for the year ending 2025.
- TAKEDA PHARMACEUTICAL CO LTD showed an increase of +0.0% in Research And Development Expense from 2024 to 2025.
- This data is from TAKEDA PHARMACEUTICAL CO LTD's annual report (Form 10-K), filed with the SEC on June 25, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), TAKEDA PHARMACEUTICAL CO LTD's Research And Development Expense has grown by 133.8%.
- Historical annual values: Fiscal year 2025: $730.23 billion | Fiscal year 2024: $729.92 billion | Fiscal year 2023: $633.33 billion | Fiscal year 2022: $526.09 billion | Fiscal year 2021: $455.83 billion | Fiscal year 2020: $492.38 billion | Fiscal year 2019: $368.30 billion | Fiscal year 2018: $325.44 billion | Fiscal year 2017: $312.30 billion.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: